COAGULATION TEST ABNORMAL side effect
What is COAGULATION TEST ABNORMAL ?Drugs associated with COAGULATION TEST ABNORMAL
ASPIRIN AUGMENTIN DACTINOMYCIN DURAGESIC FORTEO HUMIRA METHOTREXATE PREDNISONE TRACLEER WARFARINCOAGULATION TEST ABNORMAL : Duragesic Side Effects Report #5663956-5
Consumer or non-health professional from UNITED STATES reported DURAGESIC problem on Mar 04, 2008. Male patient, weighting 280.0 lb, was diagnosed with pain, nasopharyngitis and was treated with DURAGESIC. After drug was administered, patient experienced the following problems/side effects: coagulation test abnormal, epistaxis, nasopharyngitis, oedema peripheral, pain in extremity, thrombosis, urticaria, . DURAGESIC dosage: unknown. During the same period patient was treated with ZITHROMAX, VICODIN. Patient recovered.
COAGULATION TEST ABNORMAL : Forteo Side Effects Report #5613683-5
FORTEO problem was reported by a Physician from UNITED STATES on Jan 22, 2008. Female patient, 56 years of age, was treated with FORTEO. After drug was administered, patient experienced the following problems/side effects: coagulation test abnormal, contusion, convulsion, fall, hospitalisation, hot flush, . FORTEO dosage: unknown. Patient was hospitalized. Patient recovered.
COAGULATION TEST ABNORMAL : Dactinomycin Side Effects Report #5616343-X
Consumer or non-health professional from UNITED STATES reported DACTINOMYCIN problem on Feb 06, 2008. Female patient, weighting 114.0 lb, was treated with DACTINOMYCIN. After drug was administered, patient experienced the following problems/side effects: coagulation test abnormal, dehydration, gas gangrene, ileus, necrotising fasciitis, neutropenia, oliguria, pneumatosis, pyrexia, . DACTINOMYCIN dosage: 0.45 MG 0.045 MG/KG/DAY X 1 DOSE. During the same period patient was treated with VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.
COAGULATION TEST ABNORMAL : Dactinomycin Side Effects Report #5626177-8
DACTINOMYCIN problem was reported by a Consumer or non-health professional from CANADA on Feb 12, 2008. Female patient, weighting 114.0 lb, was treated with DACTINOMYCIN. After drug was administered, patient experienced the following problems/side effects: coagulation test abnormal, dehydration, diarrhoea, gas gangrene, hyperbilirubinaemia, ileus, nausea, necrotising fasciitis, neutropenia, . DACTINOMYCIN dosage: 2.3 MG 0.045 MG/KG/DAY X1 DOSE. During the same period patient was treated with VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.
COAGULATION TEST ABNORMAL : Forteo Side Effects Report #5593724-4
Consumer or non-health professional from UNITED STATES reported FORTEO problem on Jan 03, 2008. Female patient, 56 years of age, was treated with FORTEO. After drug was administered, patient experienced the following problems/side effects: coagulation test abnormal, contusion, convulsion, fall, hospitalisation, hot flush, . FORTEO dosage: unknown. Patient was hospitalized. Patient recovered.
COAGULATION TEST ABNORMAL : Humira Side Effects Report #5595070-1
HUMIRA problem was reported by a Consumer or non-health professional from CANADA on Jan 07, 2008. Female patient, weighting 150.1 lb, was diagnosed with rheumatoid arthritis and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: coagulation test abnormal, headache, . HUMIRA dosage: unknown. During the same period patient was treated with LEVOTHYROXINE. Patient was hospitalized. Patient recovered.
COAGULATION TEST ABNORMAL : Warfarin Side Effects Report #5489377-6
Physician from UNITED STATES reported WARFARIN problem on Oct 16, 2007. Female patient, weighting 255.0 lb, was diagnosed with antiphospholipid syndrome and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: coagulation test abnormal, . WARFARIN dosage: 10 MG DAILY. Patient recovered.
COAGULATION TEST ABNORMAL : Aspirin Side Effects Report #5497365-9
ASPIRIN problem was reported by a Physician from UNITED KINGDOM on Oct 11, 2007. Male patient, 62 years of age, weighting 172.0 lb, was diagnosed with thrombosis prophylaxis and was treated with ASPIRIN. After drug was administered, patient experienced the following problems/side effects: coagulation test abnormal, post procedural haemorrhage, wound secretion, . ASPIRIN dosage: 300 MG. During the same period patient was treated with HEPARIN, APROTININ, PROTAMINE SULPHATE. Patient recovered.
COAGULATION TEST ABNORMAL : Augmentin Side Effects Report #5661243-2
Consumer or non-health professional from ITALY reported AUGMENTIN problem on Mar 07, 2008. Male patient, 45 years of age, was diagnosed with infected skin ulcer and was treated with AUGMENTIN. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, coagulation test abnormal, dyspnoea, electromechanical dissociation, liver function test abnormal, loss of consciousness, renal function test abnormal, respiratory arrest, . AUGMENTIN dosage: unknown. During the same period patient was treated with WARFARIN. Patient was hospitalized. Patient recovered.
COAGULATION TEST ABNORMAL : Prednisone Side Effects Report #5683195-1
PREDNISONE problem was reported by a Consumer or non-health professional from on Mar 24, 2008. Male patient, child 10 years of age, was diagnosed with acute lymphocytic leukaemia, blood uric acid increased and was treated with PREDNISONE. After drug was administered, patient experienced the following problems/side effects: blood cholesterol increased, coagulation test abnormal, hepatic enzyme increased, hypertriglyceridaemia, pancreatitis, . PREDNISONE dosage: unknown. During the same period patient was treated with METHOTREXATE, RASBURICASE, VINCRISTINE, DAUNOMYCIN. Patient was hospitalized. Patient recovered.
COAGULATION TEST ABNORMAL : Dactinomycin Side Effects Report #5619527-X
Consumer or non-health professional from CANADA reported DACTINOMYCIN problem on Feb 05, 2008. Female patient, weighting 114.0 lb, was treated with DACTINOMYCIN. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, coagulation test abnormal, dehydration, diarrhoea, hyperbilirubinaemia, ileus, nausea, necrotising fasciitis, neutropenia, . DACTINOMYCIN dosage: .045 MG. During the same period patient was treated with VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.
COAGULATION TEST ABNORMAL : Methotrexate Side Effects Report #5678209-9
METHOTREXATE problem was reported by a Physician from SWITZERLAND on Mar 07, 2008. Male patient, child 3. years of age, was diagnosed with acute lymphocytic leukaemia and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: adenoviral hepatitis, brain hypoxia, coagulation test abnormal, coagulopathy, convulsion, febrile neutropenia, gastrointestinal haemorrhage, grand mal convulsion, . METHOTREXATE dosage: 20 MG/M2, QW, ORAL. During the same period patient was treated with VINCRISTINE, DEXAMETHASONE, MERCAPTOPURINE. Patient died.
COAGULATION TEST ABNORMAL : Humira Side Effects Report #5609164-5
Consumer or non-health professional from CANADA reported HUMIRA problem on Jan 21, 2008. Female patient, weighting 150.1 lb, was diagnosed with rheumatoid arthritis, arrhythmia and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: blood cholesterol increased, blood pressure increased, coagulation test abnormal, headache, . HUMIRA dosage: unknown. During the same period patient was treated with LEVOTHYROXINE, BISOPROLOL FUMARATE. Patient was hospitalized. Patient recovered.
COAGULATION TEST ABNORMAL : Tracleer Side Effects Report #5468297-7
TRACLEER problem was reported by a Health Professional from JAPAN on Sept 10, 2007. Female patient, 42 years of age, weighting 108.0 lb, was diagnosed with pulmonary hypertension and was treated with TRACLEER. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, coagulation test abnormal, hepatic function abnormal, . TRACLEER dosage: 125 MG, BID, ORAL, 62.5 MG, BID, ORAL, 93.75 MG, BID, ORAL. During the same period patient was treated with WARFARIN POTASSIUM, BERAPROST, FERRIC PYROPHOSPHATE, THYROID PREPARATIONS, FUROSEMIDE. Patient was hospitalized. Patient recovered.